Literature DB >> 33303644

Understanding Racial Disparities in Gastrointestinal Cancer Outcomes: Lack of Surgery Contributes to Lower Survival in African American Patients.

John N Bliton1, Michael Parides1,2, Peter Muscarella1, Katia T Papalezova1, Haejin In3,4.   

Abstract

BACKGROUND: Race/ethnicity-related differences in rates of cancer surgery and cancer mortality have been observed for gastrointestinal (GI) cancers. This study aims to estimate the extent to which differences in receipt of surgery explain racial/ethnic disparities in cancer survival.
METHODS: The National Cancer Database was used to obtain data for patients diagnosed with stage I-III mid-esophageal, distal esophagus/gastric cardia (DEGC), noncardia gastric, pancreatic, and colorectal cancer in years 2004-2015. Mediation analysis was used to identify variables influencing the relationship between race/ethnicity and mortality, including surgery.
RESULTS: A total of 600,063 patients were included in the study: 3.5% mid-esophageal, 12.4% DEGC, 4.9% noncardia gastric, 17.0% pancreatic, 40.1% colon, and 22.0% rectal cancers. The operative rates for Black patients were low relative to White patients, with absolute differences of 21.0%, 19.9%, 2.3%, 8.3%, 1.6%, and 7.7%. Adjustment for age, stage, and comorbidities revealed even lower odds of receiving surgery for Black patients compared with White patients. The observed HRs for Black patients compared with White patients ranged from 1.01 to 1.42. Mediation analysis showed that receipt of surgery and socioeconomic factors had greatest influence on the survival disparity.
CONCLUSIONS: The results of this study indicate that Black patients appear to be undertreated compared with White patients for GI cancers. The disproportionately low operative rates contribute to the known survival disparity between Black and White patients. IMPACT: Interventions to reduce barriers to surgery for Black patients should be promoted to reduce disparities in GI cancer outcomes.See related commentary by Hébert, p. 438. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 33303644      PMCID: PMC8049948          DOI: 10.1158/1055-9965.EPI-20-0950

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  5 in total

1.  Association of social determinants of health with late diagnosis and survival of patients with pancreatic cancer.

Authors:  Jesus C Fabregas; Kristen E Riley; Jeannine M Brant; Thomas J George; E John Orav; Miranda B Lam
Journal:  J Gastrointest Oncol       Date:  2022-06

2.  Impact of Medicaid Expansion on Pancreatic Cancer: An Examination of Sociodemographic Disparity in 1-Year Survival.

Authors:  Erin M Mobley; Ian Tfirn; Christina Guerrier; Michael S Gutter; Kim Vigal; Keouna Pather; Brett Baskovich; Ziad T Awad; Alexander S Parker
Journal:  J Am Coll Surg       Date:  2022-01-01       Impact factor: 6.532

3.  Evaluation of Racial Disparities in Quality of Care for Patients With Gastrointestinal Tract Cancer Treated With Surgery.

Authors:  Baylee F Bakkila; Daniel Kerekes; Marcella Nunez-Smith; Kevin G Billingsley; Nita Ahuja; Karen Wang; Carol Oladele; Caroline H Johnson; Sajid A Khan
Journal:  JAMA Netw Open       Date:  2022-04-01

4.  Female Colon Cancer Metastasis Pattern and Prognosis: A SEER-Based Study.

Authors:  Yurong Liu; Rongbin Kang; Huida Zheng; Pengcheng Wang; Weixin Jiang; Bin Xiong; Jintao Chen; Jianhua Xu
Journal:  Biomed Res Int       Date:  2022-07-07       Impact factor: 3.246

5.  Association of race and health insurance in treatment disparities of colon cancer: A retrospective analysis utilizing a national population database in the United States.

Authors:  Scarlett Hao; Rebecca A Snyder; William Irish; Alexander A Parikh
Journal:  PLoS Med       Date:  2021-10-25       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.